Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Abrams

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Pathogens (Basel, Switzerland)|August 6, 2020
Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort StudyAlfred Dusabimana, Dan Bhwana, Stephen Raimon, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>Alfred Dusabimana, Solomon Tsebeni Wafula, Stephen Jada Raimon, et al.
Epidemics|April 2, 2021
Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectoriesSteven Abrams, James Wambua, Eva Santermans, et al.
Plos Computational Biology|August 22, 2022
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2Elise J Kuylen, Andrea Torneri, Lander Willem, et al.
European Journal of Public Health|August 19, 2025
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionNeilshan Loedy, Hector G Dorta, Steven Abrams, et al.
Journal of the American College of Radiology : JACR|December 3, 2025
What a Peer-Led, Community-Engaged Lung Cancer Screening Pilot Study Taught Us About Reaching Black VeteransLauren E Kearney, Jacquelyn N Pendergast, Anushka Sista, et al.
The Lancet. Digital Health|April 9, 2025
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyHector Gonzalez Dorta, Johan Verbeeck, Jonas Crevecoeur, et al.
Nature Communications|March 22, 2021
The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19Lander Willem, Steven Abrams, Pieter J K Libin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 4, 2022
Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020Sereina Annik Herzog, Jessie De Bie, Steven Abrams, et al.
Pathogens (Basel, Switzerland)|March 14, 2020
Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of CongoMichel Mandro, Joseph Nelson Siewe Fodjo, Alfred Dusabimana, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Pathogens (Basel, Switzerland)|August 6, 2020
Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort StudyAlfred Dusabimana, Dan Bhwana, Stephen Raimon, et al.
Pathogens (Basel, Switzerland)|January 5, 2021
Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>Alfred Dusabimana, Solomon Tsebeni Wafula, Stephen Jada Raimon, et al.
Epidemics|April 2, 2021
Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectoriesSteven Abrams, James Wambua, Eva Santermans, et al.
Plos Computational Biology|August 22, 2022
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2Elise J Kuylen, Andrea Torneri, Lander Willem, et al.
European Journal of Public Health|August 19, 2025
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionNeilshan Loedy, Hector G Dorta, Steven Abrams, et al.
Journal of the American College of Radiology : JACR|December 3, 2025
What a Peer-Led, Community-Engaged Lung Cancer Screening Pilot Study Taught Us About Reaching Black VeteransLauren E Kearney, Jacquelyn N Pendergast, Anushka Sista, et al.
The Lancet. Digital Health|April 9, 2025
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyHector Gonzalez Dorta, Johan Verbeeck, Jonas Crevecoeur, et al.
Nature Communications|March 22, 2021
The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19Lander Willem, Steven Abrams, Pieter J K Libin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 4, 2022
Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020Sereina Annik Herzog, Jessie De Bie, Steven Abrams, et al.
Pathogens (Basel, Switzerland)|March 14, 2020
Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of CongoMichel Mandro, Joseph Nelson Siewe Fodjo, Alfred Dusabimana, et al.
Pageof 10